Gynecological cancer: More evidence supporting human papillomavirus testing

Nature Reviews Clinical Oncology

Volumn 9, Issue 3, 2012, Pages 131-132

  Castle, Philip E ^a  

^a American Society for Clinical Pathology Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GRADING; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CLINICAL EFFECTIVENESS; COLPOSCOPY; DIAGNOSTIC ACCURACY; EVIDENCE BASED MEDICINE; FOLLOW UP; GYNECOLOGIC CANCER; HUMAN; HUMAN PAPILLOMAVIRUS TESTING; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INTERMETHOD COMPARISON; NONHUMAN; PAPANICOLAOU TEST; PATIENT SAFETY; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; UTERINE CERVIX CARCINOMA IN SITU;

EARLY DETECTION OF CANCER; EUROPE; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; WOMEN'S HEALTH;

EID: 84857911862     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2012.16     Document Type: Short Survey

References (10)

1. Rijkaart, D. C. et al. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol. 13, 78-88 (2012).
2. Ronco, G. et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 11, 249-257 (2010).
3. Naucler, P. et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N. Engl. J. Med. 357, 1589-1597 (2007). (Pubitemid 47598401)
4. Mayrand, M. H. et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N. Engl. J. Med. 357, 1579-1588 (2007).
5. Castle, P. E. et al. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol. 12, 880-890 (2011).
6. Sankaranarayanan, R. et al. HPV screening for cervical cancer in rural India. N. Engl. J. Med. 360, 1385-1394 (2009).
7. Dillner, J. et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 337, a1754 (2008).
8. Katki, H. A. et al. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol. 12, 663-672 (2011).
9. Kitchener, H. C. et al. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol. 10, 672-682 (2009).
10. US Preventive Services Task Force. Screening for Cervical Cancer [online] http://www.uspreventiveservicestaskforce.org/3rduspstf/cervcan/cervcanrr.pdf (2012).